Cargando…

RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer

BACKGROUND: Oestrogen Receptor 1 (ESR1) mutations are frequently acquired in oestrogen receptor (ER)-positive metastatic breast cancer (MBC) patients who were treated with aromatase inhibitors (AI) in the metastatic setting. Acquired ESR1 mutations are associated with poor prognosis and there is a l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dustin, Derek, Gu, Guowei, Beyer, Amanda R., Herzog, Sarah K., Edwards, David G., Lin, Hangqing, Gonzalez, Thomas L., Grimm, Sandra L., Coarfa, Cristian, Chan, Doug W., Kim, Beom-Jun, De La O, Jean-Paul, Ellis, Matthew J., Liu, Dan, Li, Shunqiang, Welm, Alana L., Fuqua, Suzanne A. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782501/ https://www.ncbi.nlm.nih.gov/pubmed/33257837 http://dx.doi.org/10.1038/s41416-020-01174-z

Ejemplares similares

Hormonal Modulation of ESR1 Mutant Metastasis
por: Gu, Guowei, et al.
Publicado: (2020)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

Short-form Ron is a novel determinant of ovarian cancer initiation and progression
por: Moxley, Katherine M., et al.
Publicado: (2016)

mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
por: Faham, Najme, et al.
Publicado: (2018)

Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth
por: Ekiz, Huseyin Atakan, et al.
Publicado: (2018)

Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
por: Gou, Xuxu, et al.
Publicado: (2021)

Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4(+) T Cells That Subvert Immunosuppression
por: Lai, Shu-Chin Alicia, et al.
Publicado: (2021)

The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
por: Cunha, Stéphanie, et al.
Publicado: (2014)

De la caña al ron
por: Fahrasmane, L.
Publicado: (2005)

Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)
por: Zou, Yi, et al.
Publicado: (2013)

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer
por: Gou, Xuxu, et al.
Publicado: (2023)

Differentially regulated genes in Esr2-mutant rat granulosa cells
por: Khristi, Vincentaben, et al.
Publicado: (2018)

Bulevar del ron
por: Pécheral, Jacques R. (Jacques Renaud), 1908-
Publicado: (1966)

Bulevar del ron
por: Pécheral, Jacques, 1908-
Publicado: (1972)

The healing power of Ron
por: LeBrasseur, Nicole
Publicado: (2003)

Mentors: Ron Kaback
por: Carrasco, Nancy
Publicado: (2019)

AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003
por: Welm, Alana L
Publicado: (2004)

Identification of a New Rhoptry Neck Complex RON9/RON10 in the Apicomplexa Parasite Toxoplasma gondii
por: Lamarque, Mauld H., et al.
Publicado: (2012)

Toward improved models of human cancer
por: Welm, Bryan E., et al.
Publicado: (2021)

Quick Sketching with Ron Husband
por: Husband, Ron
Publicado: (2014)

RON5 Is Critical for Organization and Function of the Toxoplasma Moving Junction Complex
por: Beck, Josh R., et al.
Publicado: (2014)

The ESR Patient Advisory Group (ESR-PAG)
Publicado: (2015)

EGFR transactivates RON to drive oncogenic crosstalk
por: Franco Nitta, Carolina, et al.
Publicado: (2021)

Ron Johnston (1941–2020): in memoriam
por: Sidaway, James D., et al.
Publicado: (2020)

Ron's Place: the theatre of (personal) power
por: Slominski, Lisa
Publicado: (2022)

RON is not a prognostic marker for resectable pancreatic cancer
por: Tactacan, Carole M, et al.
Publicado: (2012)

Prediction and analysis of metagenomic operons via MetaRon: a pipeline for prediction of Metagenome and whole-genome opeRons
por: Zaidi, Syed Shujaat Ali, et al.
Publicado: (2021)

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
por: Li, Zheqi, et al.
Publicado: (2022)

Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets
por: Gates, Leah A., et al.
Publicado: (2018)

Tom Hanks and Ron Howard Space geeks
Publicado: (2009)

Tom Hanks and Ron Howard visit CERN
Publicado: (2009)

Neuroethologist Ron Hoy on College, Careers, and Crawdads
por: Ruble, Julie
Publicado: (2006)

AdipoRon may be benefit for atherosclerosis prevention
por: Esfahani, Maryam, et al.
Publicado: (2017)

Role of RONS and eIFs in Cancer Progression
por: Salaheldin, Yasmeen Ahmed, et al.
Publicado: (2021)

Significance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160
por: Lu, Yi, et al.
Publicado: (2008)

RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin
por: Zhou, Donghui, et al.
Publicado: (2019)

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
por: Lei, Jonathan T., et al.
Publicado: (2018)

ESR1 and ESR2 genotypes and the age at menarche in idiopathic scoliosis
por: Janusz, Piotr, et al.
Publicado: (2014)

Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder
por: Cheng, H-L, et al.
Publicado: (2005)

Variant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines
por: Zhou, Dong-Hui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c10q8o2hf03ngjfihbn86sf6ge